$Everolimus as a therapeutic option in refractory epilepsy in children with tuberous sclerosis: a systematic review$

Everolimus as a therapeutic option in refractory epilepsy in children with tuberous sclerosis: a systematic review

Background Tuberous sclerosis (TS) is a multisystem genetic disease in which epilepsy is a frequent manifestation and is often difficult to control. Everolimus is a drug with proven efficacy in the treatment of other conditions related to TS, and some evidence suggests that its use benefits the trea...

Full description

Bibliographic Details
Main Authors:	Catarina Ester Gomes Menezes, Débora Lopes dos Santos, Erick Santos Nery, Evelin Duarte Serpa, Lécio Aragão Souza Morais, Lucas Santana Dutra, Marcos Baruch Portela Filho, Julieta Sobreira Goes
Format:	Article
Language:	English
Published:	Academia Brasileira de Neurologia (ABNEURO) 2023-04-01
Series:	Arquivos de Neuro-Psiquiatria
Subjects:	tuberous sclerosis epilepsy everolimus tor serine-threonine kinases child
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1758442

Similar Items

Tuberous sclerosis complex
by: Alexander Jerman, et al.
Published: (2014-05-01)

Effect and Complications of Everolimus Use for Giant Cardiac Rhabdomyomas with Neonatal Tuberous Sclerosis
by: Yuka Shibata, et al.
Published: (2019-07-01)

Everolimus Treatment and Selective Artery Embolization Application in a Case of Tuberous Sclerosis-Related Bilateral Renal Angiomyolipoma
by: Ismail Emre Ergin, et al.
Published: (2023-05-01)

Everolimus improved renal function without reducing the size of a kidney angiomyolipoma in a patient with tuberous sclerosis complex: a case report
by: Akira Ashida, et al.
Published: (2018-06-01)

A retrospective analysis of the efficacy and tolerability of treatment with everolimus in treatment-refractory epilepsy associated with tuberous sclerosis
by: A. V. Grigoryeva, et al.
Published: (2020-03-01)

Experience of a Single Center in Treating Multiple Manifestations of Tuberous Sclerosis Complex with Everolimus
by: Hyunji Ahn, et al.
Published: (2019-12-01)

Everolimus Reduces the Size of Tuberous Sclerosis Complex-Related Huge Renal Angiomyolipomas Exceeding 20 cm in the Longest Diameter
by: Naoya Toriu, et al.
Published: (2018-05-01)

Everolimus induced organizing pneumonia in a patient with tuberous sclerosis complex
by: Julio Lanfranco, et al.
Published: (2021-01-01)

Efficacy and safety of Everolimus in children with TSC - associated epilepsy – Pilot data from an open single-center prospective study
by: Sharon Samueli, et al.
Published: (2016-11-01)

Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practice
by: Ine Cockerell, et al.
Published: (2023-12-01)

Paradigm shift in the treatment of tuberous sclerosis: Effectiveness of everolimus
by: Roberto Previtali, et al.
Published: (2023-09-01)

The Role of Mammalian Target of Rapamycine Signaling Pathway in Central Nervous System Cancers: A Review
by: Forough Alemi Serej, et al.
Published: (2021-01-01)

Sequential everolimus for angiomyolipoma associated with tuberous sclerosis complex: a prospective cohort study
by: Liangyou Gu, et al.
Published: (2021-06-01)

Efficacy of Everolimus Low-Dose Treatment for Cardiac Rhabdomyomas in Neonatal Tuberous Sclerosis: Case Report and Literature Review
by: Luisa Federica Nespoli, et al.
Published: (2021-03-01)

Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial
by: Yi Cai, et al.
Published: (2018-03-01)

In Vitro Interactions of Antifungal Agents and Everolimus Against Aspergillus Species
by: Huiping Jiang, et al.
Published: (2022-07-01)

Defining the Magnetic Resonance Features of Renal Lesions and Their Response to Everolimus in a Transgenic Mouse Model of Tuberous Sclerosis Complex
by: Shubhangi Agarwal, et al.
Published: (2022-06-01)

Everolimus versus sirolimus for angiomyolipoma associated with tuberous sclerosis complex: a multi-institutional retrospective study in China
by: Cong Luo, et al.
Published: (2021-07-01)

A Multi-Centric Study Assessing Safety and Efficacy of Everolimus in Adult Chinese Patients With Tuberous Sclerosis Complex Associated Renal Angiomyolipomas
by: Wenda Wang, et al.
Published: (2022-07-01)

Low-Dose Everolimus Maintenance Therapy for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex
by: Cong Luo, et al.
Published: (2021-11-01)

Efficacy of Everolimus for Treating Renal Angiomyolipoma with Inferior Vena Cava Thrombus Associated with Tuberous Sclerosis: A Case Report
by: Daiki Ikarashi, et al.
Published: (2017-02-01)

Effect of everolimus on multifocal micronodular pneumocyte hyperplasia in tuberous sclerosis complex
by: Cécile Daccord, et al.
Published: (2020-01-01)

Use of the mTOR inhibitor everolimus in a patient with multiple manifestations of tuberous sclerosis complex including epilepsy
by: James W. Wheless
Published: (2015-01-01)

Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities
by: Julio Pascual, et al.
Published: (2017-05-01)

Case report: Accelerated regression of giant cardiac rhabdomyomas in neonates with low dose everolimus
by: Daniel Hurtado-Sierra, et al.
Published: (2023-02-01)

Phase 2 study of everolimus for relapsed or refractory classical Hodgkin lymphoma
by: Patrick B. Johnston, et al.
Published: (2018-05-01)

Accelerated regression of cardiac rhabdomyoma by mTOR inhibitors in a neonate with heart failure: A case report
by: Krishna Prasad, et al.
Published: (2020-09-01)

Two cases of eczematous eruptions caused by everolimus
by: Minako Habu, et al.
Published: (2019-10-01)

UPLC-MS based integrated plasma proteomic and metabolomic profiling of TSC-RAML and its relationship with everolimus treatment
by: Zhan Wang, et al.
Published: (2023-02-01)

A Novel Class of Elicitin-like Genes from Phytophthora infestans
by: Sophien Kamoun, et al.
Published: (1997-11-01)

Antimycobacterial Effects of Everolimus in a Human Granuloma Model
by: David Ashley, et al.
Published: (2020-06-01)

Everolimus in Invasive Malignant Renal Epithelioid Angiomyolipoma
by: Gang Guo, et al.
Published: (2021-01-01)

IGF-1 influences Everolimus activity in medullary thyroid carcinoma
by: Erica eGentilin, et al.
Published: (2015-05-01)

Recomendaciones para el uso de everolimus en trasplante renal de novo: falsas creencias, mitos y realidades
by: Julio Pascual, et al.
Published: (2017-05-01)

Real-World Evidence Study on the Long-Term Safety of Everolimus in Patients With Tuberous Sclerosis Complex: Final Analysis Results
by: María Luz Ruiz-Falcó Rojas, et al.
Published: (2022-04-01)

Resolution of multifocal micronodular pneumocyte hyperplasia with everolimus in a patient with tuberous sclerosis complex
by: Tetsuaki Shoji, et al.
Published: (2021-01-01)

Management of Renal Angiomyolipomas in Tuberous Sclerosis Complex: A Case Report and Literature Review
by: Mitchell Hunter-Dickson, et al.
Published: (2022-10-01)

Massive biventricular rhabdomyoma in a neonate
by: Manish Pandey, et al.
Published: (2017-01-01)

Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system
by: Jing eJiang, et al.
Published: (2013-08-01)

Metastatic epithelioid angiomyolipoma treated with everolimus in a patient receiving hemodialysis: A case report
by: Manabu Takai, et al.
Published: (2019-09-01)